MHRA: Regulatory ‘Sandbox’ for AI Developers
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced that it is planning to establish a new AI-based "regulatory sandbox" to help artificial intelligence (AI) developers test and provide evidence for their technologies in a virtual space under regulatory monitoring. The so-called AI-Airlock is expected to go into operation in April 2024.
The use of AI is increasingly important and offers great opportunities in the healthcare sector. In the press release published on 30 October 2023, the MHRA states that "Artificial Intelligence in healthcare represents the exciting potential to improve patient outcomes in many ways, for example through improving diagnoses and treatment selections, optimising medication dosages, and providing enhanced personalised care for patients."
The advanced AI technology is a partnership between the UK government, regulators and industry, and is intended to create a space for collaboration. The Al-Airlock is funded by the Department for Science, Innovation and Technology and the Department of Health and Social Care.
Source:
MHRA: Press release
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
